Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.88 CHF | -0.91% | -1.80% | +16.01% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.01% | 544M | |
+5.08% | 43.43B | |
+48.09% | 41.69B | |
+9.80% | 41.31B | |
-10.82% | 27.14B | |
+10.33% | 25.28B | |
-24.30% | 18.47B | |
+35.58% | 12.59B | |
+2.72% | 12.33B | |
+8.06% | 11.03B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea to Get Milestone Payment from Pfizer After Antifungal Drug Sales Exceed Threshold